Approximately a quarter of the world's population is infected with tuberculosis, which is the seedbed from which all forms of ...

Alpibectir was developed in a public-private collaboration between GSK, Pasteur Institute Lille, and the University of Lille, and is designed as a companion to ethionamide (Eto), which is an important ...

Usually, TB infects the lungs — that’s pulmonary TB. But Mycobacterium tuberculosis can infect the liver, bones, spinal cord, brain, urinary tract, bladder, kidneys, and even the intestines.

CDSCO approves Bharat Biotech's phase II clinical trial for TB vaccine in India, focusing on safety and immunogenicity.

GSK (NYSE:GSK) will expand its collaboration with BioVersys AG on the development of tuberculosis candidate alpibectir as ...

The study leverages decades of cancer research to study tuberculosis-affected lung tissue and improve ...

City officials declared a public health emergency Thursday after a tuberculosis outbreak left one person dead and nine others ...

Investigators in South Korea explored the association between tuberculosis and the incidence of systemic vasculitides.

BioVersys expands collaboration with GSK to speed up development of alpibectir for treatment of tuberculosis: Basel, Switzerland Wednesday, May 8, 2024, 13:00 Hrs [IST] BioVersys ...

Strategic collaboration with GSK expanded to accelerate clinical development of alpibectir for the treatment of tuberculosis GSK to participate ... in a Phase 2a proof-of-concept study in pulmonary TB ...